Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer

Human Molecular Genetics

Volumn 20, Issue 19, 2011, Pages 3746-3756

  Stine, Zachary E ^a   McGaughey, David M ^a   Bessling, Seneca L ^a   Li, Shengchao ^b   McCallion, Andrew S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; PROTEIN RET; RETINOIC ACID RECEPTOR ALPHA; STEROID HORMONE;

ANIMAL CELL; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CENTRAL NERVOUS SYSTEM; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; ESTROGEN RESPONSIVE ELEMENT; GENE LOCUS; HUMAN; HUMAN CELL; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; REGULATORY MECHANISM; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; TRANSGENICS; ZEBRA FISH;

ANIMALS; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; ENHANCER ELEMENTS, GENETIC; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-RET; RESPONSE ELEMENTS; TRETINOIN; ZEBRAFISH;

DANIO RERIO;

EID: 80052725661     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr291     Document Type: Article

References (64)

1. Marcos-Gutiérrez, C.V., Wilson, S.W., Holder, N. and Pachnis, V. (1997) The zebrafish homologue of the ret receptor and its pattern of expression during embryogenesis. Oncogene, 14, 879-889.
2. Golden, J.P., Baloh, R.H., Kotzbauer, P.T., Lampe, P.A., Osborne, P.A., Milbrandt, J. and Johnson, E.M. (1998) Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J. Comp. Neurol., 398, 139-150.
3. Golden, J.P., DeMaro, J.A., Osborne, P.A., Milbrandt, J. and Johnson, E.M. (1999) Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse. Exp. Neurol., 158, 504-528.
4. Mulligan, L.M., Eng, C., Healey, C.S., Clayton, D., Kwok, J.B., Gardner, E., Ponder, M.A., Frilling, A., Jackson, C.E. and Lehnert, H. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat. Genet., 6, 70-74.
5. Edery, P., Lyonnet, S., Mulligan, L.M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fékété, C., Ponder, B.A. and Munnich, A. (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature, 367, 378-380.
6. Emison, E.S., McCallion, A.S., Kashuk, C.S., Bush, R.T., Grice, E., Lin, S., Portnoy, M.E., Cutler, D.J., Green, E.D. and Chakravarti, A. (2005) A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature, 434, 857-863.
7. de Pontual, L., Zaghloul, N.A., Thomas, S., Davis, E.E., McGaughey, D.M., Dollfus, H., Baumann, C., Bessling, S.L., Babarit, C., Pelet, A. et al. (2009) Epistasis between RET and BBS mutations modulates enteric innervation and causes syndromic Hirschsprung disease. PNAS, 106, 13921-13926.
8. Plaza-Menacho, I., Morandi, A., Robertson, D., Pancholi, S., Drury, S., Dowsett, M., Martin, L.A. and Isacke, C.M. (2010) Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance. Oncogene, 29, 4648-4657.
9. Morandi, A., Plaza-Menacho, I. and Isacke, C.M. (2011) RET in breast cancer: functional and therapeutic implications. Trends Mol. Med., 17, 149-157.
10. Kang, J., Qian, P.X., Pandey, V., Perry, J.K., Miller, L.D., Liu, E.T., Zhu, T., Liu, D.X. and Lobie, P.E. (2010) Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma. Oncogene, 29, 3228-3240.
11. Kan, Z., Jaiswal, B.S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H.M., Yue, P., Haverty, P.M., Bourgon, R., Zheng, J. et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature, 466, 869-873.
12. Esseghir, S., Todd, S.K., Hunt, T., Poulsom, R., Plaza-Menacho, I., Reis-Filho, J.S. and Isacke, C.M. (2007) A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer. Cancer Res., 67, 11732-11741.
13. Boulay, A., Breuleux, M., Stephan, C., Fux, C., Brisken, C., Fiche, M., Wartmann, M., Stumm, M., Lane, H.A. and Hynes, N.E. (2008) The ret receptor tyrosine kinase pathway functionally interacts with the ER{alpha} pathway in breast cancer. Cancer Res., 68, 3743-3751.
14. Tozlu, S., Girault, I., Vacher, S., Vendrell, J., Andrieu, C., Spyratos, F., Cohen, P., Lidereau, R. and Bieche, I. (2006) Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr. Relat. Cancer, 13, 1109-1120.
15. Unger, K., Wienberg, J., Riches, A., Hieber, L., Walch, A., Brown, A., O'Brien, P.C., Briscoe, C., Gray, L., Rodriguez, E. et al. (2010) Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations. Endocr. Relat. Cancer, 17, 87-98.
16. Portella, G., Salvatore, D., Botti, G., Cerrato, A., Zhang, L., Mineo, A., Chiappetta, G., Santelli, G., Pozzi, L., Vecchio, G. et al. (1996) Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. Oncogene, 13, 2021-2026.
17. Kang, J., Qian, P.X., Pandey, V., Perry, J.K., Miller, L.D., Liu, E.T., Zhu, T., Liu, D.X. and Lobie, P.E. (2010) Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma. Oncogene, 29, 3228-3240.
18. Plaza-Menacho, I., Morandi, A., Robertson, D., Pancholi, S., Drury, S., Dowsett, M., Martin, L.A. and Isacke, C.M. (2010) Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance. Oncogene, 29, 4648-4657.
19. Moreau, E., Vilar, J., Lelievre-Pegorier, M., Merlet-Benichou, C. and Gilbert, T. (1998) Regulation of c-ret expression by retinoic acid in rat metanephros: implication in nephron mass control. Am. J. Physiol., 275, F938-F945.
20. Carroll, J.S., Meyer, C.A., Song, J., Li, W., Geistlinger, T.R., Eeckhoute, J., Brodsky, A.S., Keeton, E.K., Fertuck, K.C., Hall, G.F. et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat. Genet., 38, 1289-1297.
21. Walker, K.A., Caruana, G., Bertram, J.F. and McInnes, K.J. (2009) Sexual dimorphism in mouse metanephroi exposed to 17 beta-estradiol in vitro. Nephron Exp. Nephrol., 111, e42-e50.
22. Fu, M., Sato, Y., Lyons-Warren, A., Zhang, B., Kane, M.A., Napoli, J.L. and Heuckeroth, R.O. (2010) Vitamin A facilitates enteric nervous system precursor migration by reducing Pten accumulation. Development, 137, 631-640.
23. Oppenheimer, O., Cheung, N.-K. and Gerald, W.L. (2007) The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma. Mol. Cancer Ther., 6, 1300-1309.
24. Batourina, E., Gim, S., Bello, N., Shy, M., Clagett-Dame, M., Srinivas, S., Costantini, F. and Mendelsohn, C. (2001) Vitamin A controls epithelial/mesenchymal interactions through Ret expression. Nat. Genet., 27, 74-78.
25. Rochette-Egly, C. and Germain, P. (2009) Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl. Recept. Signal., 7, e005.
26. Welboren, W.-J., Sweep, F.C.G.J., Span, P.N. and Stunnenberg, H.G. (2009) Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated? Endocr. Relat. Cancer, 16, 1073-1089.
27. Rosselot, C., Spraggon, L., Chia, I., Batourina, E., Riccio, P., Lu, B., Niederreither, K., Dolle, P., Duester, G., Chambon, P. et al. (2010) Non-cell-autonomous retinoid signaling is crucial for renal development. Development, 137, 283-292.
28. Yamada, S., Nomura, T., Uebersax, L., Matsumoto, K., Fujita, S., Miyake, M. and Miyake, J. (2007) Retinoic acid induces functional c-Ret tyrosine kinase in human neuroblastoma. Neuroreport, 18, 359-363.
29. Hua, S., Kittler, R. and White, K.P. (2009) Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell, 137, 1259-1271.
30. Lin, C.-Y., Vega, V.B., Thomsen, J.S., Zhang, T., Kong, S.L., Xie, M., Chiu, K.P., Lipovich, L., Barnett, D.H., Stossi, F. et al. (2007) Whole-genome cartography of estrogen receptor α binding sites. PLoS Genet., 3, e87.
31. Bhat-Nakshatri, P., Wang, G., Appaiah, H., Luktuke, N., Carroll, J.S., Geistlinger, T.R., Brown, M., Badve, S., Liu, Y. and Nakshatri, H. (2008) AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer. Mol. Cell Biol., 28, 7487-7503.
32. Ross-Innes, C.S., Stark, R., Holmes, K.A., Schmidt, D., Spyrou, C., Russell, R., Massie, C.E., Vowler, S.L., Eldridge, M. and Carroll, J.S. (2010) Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev., 24, 171-182.
33. Welboren, W.-J., van Driel, M.A., Janssen-Megens, E.M., van Heeringen, S.J., Sweep, F.C., Span, P.N. and Stunnenberg, H.G. (2009) ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J., 28, 1418-1428.
34. Grice, E.A., Rochelle, E.S., Green, E.D., Chakravarti, A. and McCallion, A.S. (2005) Evaluation of the RET regulatory landscape reveals the biological relevance of a HSCR-implicated enhancer. Hum. Mol. Genet., 14, 3837-3845.
35. Fisher, S., Grice, E.A., Vinton, R.M., Bessling, S.L. and McCallion, A.S. (2006) Conservation of RET regulatory function from human to zebrafish without sequence similarity. Science, 312, 276-279.
36. Angrisano, T., Sacchetti, S., Natale, F., Cerrato, A., Pero, R., Keller, S., Peluso, S., Perillo, B., Avvedimento, V.E., Fusco, A. et al. (2010) Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. Nucleic Acids Res.
37. Fullwood, M.J., Liu, M.H., Pan, Y.F., Liu, J., Xu, H., Mohamed, Y.B., Orlov, Y.L., Velkov, S., Ho, A., Mei, P.H. et al. (2009) An oestrogen-receptor-alpha-bound human chromatin interactome. Nature, 462, 58-64.
38. Dekker, J. (2006) The three 'C' s of chromosome conformation capture: controls, controls, controls. Nat. Methods, 3, 17-21.
39. Amano, T., Sagai, T., Tanabe, H., Mizushina, Y., Nakazawa, H. and Shiroishi, T. (2009) Chromosomal dynamics at the Shh locus: limb bud-specific differential regulation of competence and active transcription. Dev. Cell, 16, 47-57.
40. Visel, A., Akiyama, J.A., Shoukry, M., Afzal, V., Rubin, E.M. and Pennacchio, L.A. (2009) Functional autonomy of distant-acting human enhancers. Genomics, 93, 509-513.
41. Liu, X., Prabhu, A. and Van Ness, B. (1999) Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3' enhancer that affect synergy with the intron enhancer. J. Biol. Chem., 274, 3285-3293.
42. Gheldof, N., Smith, E.M., Tabuchi, T.M., Koch, C.M., Dunham, I., Stamatoyannopoulos, J.A. and Dekker, J. (2010) Cell-type-specific long-range looping interactions identify distant regulatory elements of the CFTR gene. Nucleic Acids Res., 38, 4325-4336.
43. Bourdeau, V., Deschênes, J., Laperriere, D., Aid, M., White, J.H. and Mader, S. (2008) Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells. Nucleic Acids Res., 36, 76-93.
44. Lupien, M., Eeckhoute, J., Meyer, C.A., Wang, Q., Zhang, Y., Li, W., Carroll, J.S., Liu, X.S. and Brown, M. (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell, 132, 958-970.
45. Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M. and Werner, T. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics, 21, 2933-2942.
46. Matys, V., Kel-Margoulis, O.V., Fricke, E., Liebich, I., Land, S., Barre-Dirrie, A., Reuter, I., Chekmenev, D., Krull, M., Hornischer, K. et al. (2006) TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res., 34, D108-D110.
47. Birney, E., Stamatoyannopoulos, J.A., Dutta, A., Guigo, R., Gingeras, T.R., Margulies, E.H., Weng, Z., Snyder, M., Dermitzakis, E.T., Thurman, R.E. et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816.
48. John, S., Sabo, P.J., Thurman, R.E., Sung, M.H., Biddie, S.C., Johnson, T.A., Hager, G.L. and Stamatoyannopoulos, J.A. (2011) Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet., 43, 264-268.
49. Woodfield, G.W., Chen, Y., Bair, T.B., Domann, F.E. and Weigel, R.J. (2010) Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells. Genes Chromosomes Cancer, 49, 948-962.
50. Loots, G.G. and Ovcharenko, I. (2004) rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res., 32, W217-W221.
51. Yamaguchi, N., Ito, E., Azuma, S., Honma, R., Yanagisawa, Y., Nishikawa, A., Kawamura, M., Imai, J., Tatsuta, K., Inoue, J. et al. (2008) FoxA1 as a lineage-specific oncogene in luminal type breast cancer. Biochem. Biophys. Res. Commun., 365, 711-717.
52. Fisher, S., Grice, E.A., Vinton, R.M., Bessling, S.L., Urasaki, A., Kawakami, K. and McCallion, A.S. (2006) Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish. Nat. Protoc., 1, 1297-1305.
53. Bisgrove, B.W., Raible, D.W., Walter, V., Eisen, J.S. and Grunwald, D.J. (1997) Expression of c-ret in the zebrafish embryo: potential roles in motoneuronal development. J. Neurobiol., 33, 749-768.
54. Schmidt, D., Schwalie, P.C., Ross-Innes, C.S., Hurtado, A., Brown, G.D., Carroll, J.S., Flicek, P. and Odom, D.T. (2010) A CTCF-independent role for cohesin in tissue-specific transcription. Genome Res., 20, 578-588.
55. Joseph, R., Orlov, Y.L., Huss, M., Sun, W., Kong, S.L., Ukil, L., Pan, Y.F., Li, G., Lim, M., Thomsen, J.S. et al. (2010) Integrative model of genomic factors for determining binding site selection by estrogen receptor-alpha. Mol. Syst. Biol., 6, 456.
56. Guler, G., Iliopoulos, D., Guler, N., Himmetoglu, C., Hayran, M. and Huebner, K. (2007) Wwox and Ap2gamma expression levels predict tamoxifen response. Clin. Cancer Res., 13, 6115-6121.
57. Gee, J.M., Eloranta, J.J., Ibbitt, J.C., Robertson, J.F., Ellis, I.O., Williams, T., Nicholson, R.I. and Hurst, H.C. (2009) Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival. J. Pathol., 217, 32-41.
58. Louie, M.C., McClellan, A., Siewit, C. and Kawabata, L. (2010) Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance. Mol. Cancer Res., 8, 343-352.
59. Aguilar, H., Sole, X., Bonifaci, N., Serra-Musach, J., Islam, A., Lopez-Bigas, N., Mendez-Pertuz, M., Beijersbergen, R.L., Lazaro, C., Urruticoechea, A. et al. (2010) Biological reprogramming in acquired resistance to endocrine therapy of breast cancer. Oncogene, 29, 6071-6083.
60. Lanz, R.B., Bulynko, Y., Malovannaya, A., Labhart, P., Wang, L., Li, W., Qin, J., Harper, M. and O'Malley, B.W. (2010) Global characterization of transcriptional impact of the SRC-3 coregulator. Mol. Endocrinol., 24, 859-872.
61. Louie, M.C., Zou, J.X., Rabinovich, A. and Chen, H.W. (2004) ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol. Cell Biol., 24, 5157-5171.
62. Temple, G., Gerhard, D.S., Rasooly, R., Feingold, E.A., Good, P.J., Robinson, C., Mandich, A., Derge, J.G., Lewis, J., Shoaf, D. et al. (2009) The completion of the Mammalian Gene Collection (MGC). Genome Res., 19, 2324-2333.
63. McGaughey, D.M., Stine, Z.E., Huynh, J.L., Vinton, R.M. and McCallion, A.S. (2009) Asymmetrical distribution of non-conserved regulatory sequences at PHOX2B is reflected at the ENCODE loci and illuminates a possible genome-wide trend. BMC Genomics, 10, 8.
64. McGaughey, D.M., Vinton, R.M., Huynh, J., Al-Saif, A., Beer, M.A. and McCallion, A.S. (2008) Metrics of sequence constraint overlook regulatory sequences in an exhaustive analysis at phox2b. Genome Res., 18, 252-260.